Travere Therapeutics
16 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Travere Therapeutics
Federal lobbying records
Bills it lobbied on8 of 11
HR 1518 New Era of Preventing End-Stage Kidney Disease Act16 reports · In committeeHR 1414 Cameron’s Law15 reports · In committeeHR 946 ORPHAN Cures Act15 reports · In committeeHR 1262 Mikaela Naylon Give Kids a Chance Act13 reports · Passed one chamberS 1040 Drug Competition Enhancement Act10 reports · On the floor calendarHR 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 149 reports · Became lawS 1862 ORPHAN Cures Act8 reports · In committeeHR 4709 Newborn Screening Saves Lives Reauthorization Act of 20256 reports · In committeeLawmakers it funded or lobbied8 of 11
Gus BilirakisLeads 1 of these billsJodey ArringtonLeads 1 of these billsJohn BarrassoLeads 1 of these billsJohn CornynLeads 1 of these billsJohn JoyceLeads 1 of these billsJosh GottheimerLeads 1 of these billsKelly MorrisonLeads 1 of these billsMichael McCaulLeads 1 of these billsEvery link on this map
The same connections as a table, with the reason each one is here.
| HR 1518 | Bills it lobbied on | Travere Therapeutics named HR 1518, “New Era of Preventing End-Stage Kidney Disease Act”, in 16 lobbying reports. | 16 reports |
| HR 1414 | Bills it lobbied on | Travere Therapeutics named HR 1414, “Cameron’s Law”, in 15 lobbying reports. | 15 reports |
| HR 946 | Bills it lobbied on | Travere Therapeutics named HR 946, “ORPHAN Cures Act”, in 15 lobbying reports. | 15 reports |
| HR 1262 | Bills it lobbied on | Travere Therapeutics named HR 1262, “Mikaela Naylon Give Kids a Chance Act”, in 13 lobbying reports. | 13 reports |
| S 1040 | Bills it lobbied on | Travere Therapeutics named S 1040, “Drug Competition Enhancement Act”, in 10 lobbying reports. | 10 reports |
| HR 1 | Bills it lobbied on | Travere Therapeutics named HR 1, “An act to provide for reconciliation pursuant to title II of H. Con. Res. 14”, in 9 lobbying reports. | 9 reports |
| S 1862 | Bills it lobbied on | Travere Therapeutics named S 1862, “ORPHAN Cures Act”, in 8 lobbying reports. | 8 reports |
| HR 4709 | Bills it lobbied on | Travere Therapeutics named HR 4709, “Newborn Screening Saves Lives Reauthorization Act of 2025”, in 6 lobbying reports. | 6 reports |
| Gus Bilirakis | Lawmakers it funded or lobbied | Gus Bilirakis leads 1 bill Travere Therapeutics lobbied on. | Leads 1 of these bills |
| Jodey Arrington | Lawmakers it funded or lobbied | Jodey Arrington leads 1 bill Travere Therapeutics lobbied on. | Leads 1 of these bills |
| John Barrasso | Lawmakers it funded or lobbied | John Barrasso leads 1 bill Travere Therapeutics lobbied on. | Leads 1 of these bills |
| John Cornyn | Lawmakers it funded or lobbied | John Cornyn leads 1 bill Travere Therapeutics lobbied on. | Leads 1 of these bills |
| John Joyce | Lawmakers it funded or lobbied | John Joyce leads 1 bill Travere Therapeutics lobbied on. | Leads 1 of these bills |
| Josh Gottheimer | Lawmakers it funded or lobbied | Josh Gottheimer leads 1 bill Travere Therapeutics lobbied on. | Leads 1 of these bills |
| Kelly Morrison | Lawmakers it funded or lobbied | Kelly Morrison leads 1 bill Travere Therapeutics lobbied on. | Leads 1 of these bills |
| Michael McCaul | Lawmakers it funded or lobbied | Michael McCaul leads 1 bill Travere Therapeutics lobbied on. | Leads 1 of these bills |